Boehringer Ingelheim

Boehringer Ingelheim pledges €120M to expand Greek plant, add capacity for Jardiance
Fierce Pharma
Fri, 01/12/24 - 09:55 am
Boehringer Ingelheim
drug manufacturing
Greece
Jardiance
Most extensive cirrhosis £30M study funded by Boehringer Ingelheim
Outsourcing Pharma
Mon, 01/8/24 - 11:26 am
Boehringer Ingelheim
liver cirrhosis
funding
Beleaguered Theravance logs head-to-head trial loss for Yupelri against Boehringer's Spiriva
Fierce Pharma
Sun, 01/7/24 - 04:07 pm
Theravance
Yupelri
COPD
Boehringer Ingelheim
Spiriva
Boehringer bets $2B in biobucks to unlock siRNA targets for NASH treatments
Fierce Biotech
Wed, 01/3/24 - 09:40 am
Boehringer Ingelheim
biobucks
NASH
siRNA
Suzhou Ribo
Ribocure
3 standout digital innovations in pharma this year
Pharma Voice
Mon, 12/4/23 - 09:44 am
IDEA Pharma
innovation
digital pharma
AstraZeneca
Roche
Boehringer Ingelheim
Boehringer Ingelheim to collaborate with Phenomic AI on stroma-rich cancers
Medical Marketing and Media
Wed, 11/29/23 - 11:38 pm
Boehringer Ingelheim
artificial intelligence
Phenomic AI
stroma-rich cancers
Boehringer plugs in IBM-trained AI model to boost antibody drug discovery efforts
Fierce Biotech
Tue, 11/28/23 - 10:18 am
Boehringer Ingelheim
artificial intelligence
IBM
machine learnings
drug discovery
Skyrizi goes sky-high in October among Rx, OTC pharma brands
Medical Marketing and Media
Sun, 11/12/23 - 09:19 pm
Boehringer Ingelheim
AbbVie
Skyrizi
DTC advertising
pharma advertising
Boehringer clears blues to go green, unveiling new corporate branding to convey 'unwavering optimism'
Fierce Pharma
Thu, 11/9/23 - 09:51 am
Boehringer Ingelheim
branding
AbbVie, AstraZeneca, Boehringer and more face FTC's ire for 'improper' patent listings
Fierce Pharma
Tue, 11/7/23 - 11:08 pm
FTC
Orange Book
patents
AbbVie
AstraZeneca
Boehringer Ingelheim
EU Commission fines pharma companies for price fixing
Reuters
Mon, 10/23/23 - 09:36 am
Europe
API
price fixing
antitrust
Alkaloids
Linnea
Boehringer Ingelheim
Transo-Pharm
Chasing Boehringer, Anaptys hits goal in pivotal rare skin disease trial, plans out-licensing deal
Fierce Biotech
Mon, 10/9/23 - 10:11 am
AnaptysBio
generalized pustular psoriasis
clinical trials
imsidolimab
Boehringer Ingelheim
Boehringer moves obesity therapy into phase 3
Pharmaphorum
Fri, 10/6/23 - 10:01 am
Boehringer Ingelheim
Zealand Pharma
clinical trials
obesity
survodutide
Boehringer Ingelheim embraces dual-pricing tactic with launch of unbranded Humira biosimilar
Fierce Pharma
Wed, 10/4/23 - 11:21 am
Boehringer Ingelheim
Cyltezo
biosimilars
Humira
drug pricing
Boehringer launches 81% discounted biosimilar of AbbVie's Humira
Reuters
Mon, 10/2/23 - 06:34 pm
Boehringer Ingelheim
biosimilars
AbbVie
Humira
unbranded biosimilars
FDA greenlights Jardiance for treating chronic kidney disease
Medical Marketing and Media
Fri, 09/22/23 - 11:50 am
Eli Lilly
Boehringer Ingelheim
Medicare
Jardiance
FDA
chronic kidney disease
Biden administration lists 10 drugs for Medicare price negotiation
Medical Marketing and Media
Tue, 08/29/23 - 11:43 am
Medicare
HHS
Pfizer
Bristol Myers Squibb
Eli Lilly
Boehringer Ingelheim
AstraZeneca
AbbVie
Novo Nordisk
JNJ
drug pricing
Boehringer Ingelheim Joins Legal Battle Against IRA Drug Pricing Provisions
BioSpace
Tue, 08/22/23 - 09:49 am
Boehringer Ingelheim
drug pricing
legal
Medicare
Inflation Reduction Act
Boehringer preps phase 3 for dual-action obesity drug
Pharmaphorum
Thu, 08/17/23 - 09:54 am
Boehringer Ingelheim
clinical trials
obesity
survodutide
The 10 drugs that CMS might wrangle into negotiations
Beckers Hospital Review
Wed, 08/16/23 - 10:16 am
CMS
Medicare
drug pricing
Bristol Myers Squibb
Janssen
Merck
Pfizer
Amgen
Boehringer Ingelheim
Pharmacyclics
AstraZeneca
Astellas
GSK

Pages